Greenhouse Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,765
Closed -$281K 54
2021
Q4
$281K Buy
4,765
+15
+0.3% +$743 0.25% 41
2021
Q3
$204K Buy
+4,750
New +$210K 0.19% 48
2021
Q1
Sell
-2,750
Closed -$101K 103
2020
Q4
$101K Buy
+2,750
New +$101K 0.1% 79

Other funds holding PFE

Greenhouse Wealth Management's PFE Position: Q1 2022 in Review

Greenhouse Wealth Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 4,765 shares — an estimated $281K sold.

Greenhouse Wealth Management first reported a position in PFE in Q4 2020 and held it in 3 quarters. The position peaked at $281K in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Greenhouse Wealth Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Greenhouse Wealth Management sold 4,765 Pfizer shares in Q1 2022, an estimated $281K.
  • Greenhouse Wealth Management first reported a position in Pfizer in Q4 2020 and held it in 3 quarters.
  • Greenhouse Wealth Management's Pfizer position peaked at $281K in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Greenhouse Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.